News
Sixty seconds on . . . psilocybin
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2775 (Published 18 May 2016) Cite this as: BMJ 2016;353:i2775
- Nigel Hawkes
- London
Shades of Aldous Huxley and Timothy Leary—are magic mushrooms back on the menu?
Not so fast. There’s a long way to go. But a study in London has shown that the active ingredient in magic mushrooms, psilocybin, may be effective against treatment resistant depression. Its effects were quick—within a week—and more than 40% of the patients treated were still in remission three months later.1
Good news, surely?
Yes, as far as it goes. These were people whose depression had …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.